Next Article in Journal
Fatal Canine Leptospirosis on St. Kitts
Previous Article in Journal
Comparative Aspects of Human, Canine, and Feline Obesity and Factors Predicting Progression to Diabetes
Article Menu

Export Article

Open AccessReview
Vet. Sci. 2014, 1(3), 136-149; doi:10.3390/vetsci1030136

Sublingual Immunotherapy in Human and Canine Atopic Dermatitis: A Mini Review

1
Department of Dermatology, Corlu Military Hospital, 59850 Corlu, Tekirdag 59850, Turkey
2
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA
*
Author to whom correspondence should be addressed.
Received: 17 July 2014 / Revised: 22 September 2014 / Accepted: 23 September 2014 / Published: 13 October 2014
View Full-Text   |   Download PDF [93 KB, uploaded 13 October 2014]

Abstract

Atopic Dermatitis (AD) is a prevalent disease that affects both humans and animals. Dogs share similar environments with the owners and spontaneously develop a disease that is clinically and immunologically identical to AD in humans. In past decades AD has become more and more common in both dogs and humans, possibly due to the increased exposure to indoor allergens and decreased exposure to parasites and beneficial bacteria. The allergic component plays an important role in both species. Allergen specific immunotherapy (ASIT) has been used with great success in veterinary medicine for decades for the treatment of AD and traditionally has been accomplished with subcutaneous injections. In human medicine, ASIT has been traditionally used for respiratory manifestations of atopic disease and only recently considered for the therapy of AD. Interestingly, dogs primarily express cutaneous manifestations of atopic disease and only rarely progress from cutaneous into respiratory disease, a process referred in human medicine as “atopic march”. Recently, sublingual immunotherapy has been replacing subcutaneous immunotherapy both in human and veterinary medicine due to its ease and safety, leading to increased compliance. The purpose of this mini review is to focus on the use of sublingual immunotherapy for AD highlighting similarities and differences between humans and dogs. View Full-Text
Keywords: immunotherapy; sublingual; atopic dermatitis; dog; human immunotherapy; sublingual; atopic dermatitis; dog; human
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ozmen, I.; Marsella, R. Sublingual Immunotherapy in Human and Canine Atopic Dermatitis: A Mini Review. Vet. Sci. 2014, 1, 136-149.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vet. Sci. EISSN 2306-7381 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top